Publikācijas » Search Results » 2016 » Konferences » Drukāšanas versija (formatēta)

Konferences
Ošiņa K.; Germini D.; Botha S.; Vassetzky Y.; Sjakste T.; Sjakste N. 1,4-dihydropyridine derivatives decrease Tat induced γH2AX expression in B lymphocytes. 74th Conference of the University of Latvia, Riga, 2016; 49.      

Rostoka E ; Ošiņa K.; Isajevs S.; Bisenieks E.; Sjakste N. Jaunu 1,4-DHP atvasinājumu DNS molekulas integritāti pasargājošo un antioksidatīvo īpašību izvērtējums 1. tipa cukura diabēta apstākļos žurkās. Latvijas Universitātes 74. konference, Rīga, 2016; 61.      

Sjakste N.; Leonova E.; Baumane L.; Rostoka E. DNA binding properties of a series of novel derivatives of 1,4-dihydropyridine. International Conference on Environmental and ocuupational Health ICOETOX; Porto, June 20-24, 2016; 82.      

Rostoka E ; Baumane L.; Isajevs S.; Sjakste N. Modification of NO production and NOS expression by polyphenols. 6th Global Summit on Medicinal and Aromatic Plants; Riga, Latvia, May 23-26, 2016.      

Ošiņa K.; Rostoka E ; Sjakste T.; Sjakste N. Psma6 gene expression is affected by 1,4-dihydropyridine derivatives in rat kidneys and blood in streptozotocin induced diabetes mellitus. Abstracts of the 58th International scientific conference of Daugavpils University; Daugavpils Universitātes Akadēmiskais apgāds “Saule”, 2016; 99.      

Leonova E.; Rostoka E.; Saivaigo S.; Baumane L.; Borisivs V.; Sada Bou; Bisenieks E.; Vassetzky Y.; Duburs G.; Sjakste N. Oxidative stress reduction and DNA repair enhancement by 1,4-dihydropiridine AV-153. Abstracts of the 58th International scientific conference of Daugavpils University; Daugavpils Universitātes Akadēmiskais apgāds “Saule”, 2016; 98.      

Sokolovska J.; Paramonova N.; Sjakste N.; Sjakste T. Genetic variations in the PSMA3, PSMA6 and PSMC6 genes are associated with type 1 diabetes in Latvians. Latvijas Universitātes 74. konference; Rīga, Latvija, 2016; 63.      

Romanchikova N.; Strods A.; Strazdina J.; Strumfs B.; Trapencieris P. Study of Novel Aziridine-Based Brutonis Tyrosine Kinase Inhibitor in Mantle Cell Lymphoma. IARC50, France, Lyon, June 7-10, 2016.      

Valtenbergs O.; Zarins A.; Kizane G.; Supe A.; Baumane L. Radiolysis of lithium orthosilicate pebbles with addition of titanium dioxide. 59th International Conference for Students of Physics and Natural Sciences; Lithuania, Vilnius, March 15-18, 2016; 217.      

Zarins A.; Kizane G.; Supe A.; Valtenbergs O.; Tamulevičius S.; Andrulevičius M.; Pajuste E.; Rudovica V.; Baumane L.; Kolb M.H.H.; Leys O.; Knitter R. Characterisation and radiolysis of modified lithium orthosilicate pebbles with addition of noble metals. 29th Symposium on Fusion Technolgy (SOFT 2016); Czech Republic, Prague, September 5-9, 2016; 612.      

Volska K.; Liepinsh E.; Makarova E.; Makrecka - Kuka M.; Kuka J.; Dambrova M. Mitochondrial damage imduces by the accumulation of acyl-coenzymes A and acylcarnitines during ischemia. FEBS workshop: Coenzyme A and its derivatives in health and disease; Marseille, France, August 23 – 27, 2016; 51.      

Makrecka M.; Kuka J.; Volska K.; Makarova E.; Sevostjanovs E.; Dambrova M.; Liepinsh E. Long-chain acylCoAs vs acylcarnitines in mitochondrial bioenergetics: from in vitro to in vivo ( http://www.bioblast.at/index.php/Makrecka-Kuka_2016_Abstract_MitoFit_Science_Camp_2016). MitoFit Science Camp; Kuhtai, Austria, July 7-13, 2016.      

Makarova E.; Makrecka - Kuka M.; Grīnberga S.; Dambrova M.; Liepinsh E. Accumulation of acylcarnitines is related to insulin resistance in diabetic Db/db and high fat diet-fed mice. FEBS, Molecular basis of human diseases: 50 years anniversary of Spetses summer schools; Spetses, Greece, May 27 – June 1, 2016; 55.      

Dambrova M.; Volska K.; Makrecka-Kuka M.; Makarova E.; Kuka J.; Vilskersts R.; Liepinsh E. Cardioprotective effects of pharmacologically decreased long-chain acylcarnitine contents in experimental models of myocardial infarction, atherosclerosis, and diabetes. The 7th European Congress of Pharmacology (EPHAR2016); Istanbul, Turkey, June 26-30, 2016; 81.      

Latkovskis G.; Mazule M.; Bondare L.; Konrade I.; Makarova E.; Hartmane D.; Strele I.; Dambrova M. Trimethylamine-N-oxide level of patients with metabolic syndrome. The 12th Warsaw International Medical Congress; Warsaw, Poland, May 12-15, 2016; 151.      

Liepinsh E.; Kuka J.; Dambrova M. Long chain acylcarnitines: new target to prevent ischemia-reperfusion induced damage in heart mitochondria. Mitochondrial Medicine: developing new treatments for mitochondrial disease 2016; Hinxton, Cambridge, UK, May 4-6, 2016; 58.      

Kuka J.; Makrecka - Kuka M.; Liepinsh E.; Dambrova M. Trimethylamine N-oxide impairs substrate oxidation in heart mitochondria. Mitochondrial Medicine: developing new treatments for mitochondrial disease 2016; Hinxton, Cambridge, UK, May 4-6, 2016; 56.      

Voļska K.; Kūka J.; Makrecka-Kuka M.; Garcia-Mauriño M. Alonso; Dambrova M. Garķēžu acil-karnitīnu nozīme sirds išēmijas-reperfūzijas bojājuma attīstībā. RSU 2016. gada zinātniskā konference, Latvijas iedzīvotāju veselību apdraudošo eksogēno un endogēno faktoru izpēte; Latvija, Rīga, 17. un 18. marts, 2016; 65.      

Makrecka-Kuka M.; Kūka J.; Voļska K.; Vilšķērsts R.; Bandere D.; Dambrova M. Trimetilamīna N-oksīda ietekme uz mitohondriālo enerģijas metabolismu. RSU 2016. gada zinātniskā konference, Latvijas iedzīvotāju veselību apdraudošo eksogēno un endogēno faktoru izpēte; Rīga, Latvija 17. un 18. marts, 2016; 69.      

Latkovskis G.; Bondare D.; Mažule M.; Konrāde I.; Makarova E.; Hartmane D.; Strēle I.; Dambrova M. Trimetilamonija oksīda līmenis pacientiem ar metabolisko sindromu. LU 74. zinātniskā konference, Internās medicīnas, kardioloģijas un infektoloģijas sekcija; Rīga, Latvija, 19. februāris, 2016; 79.      

Makarova E.; Zariņa R.; Muceniece R.; Hartmane D.; Kūka J.; Liepinsh E.; Dambrova M. Plazmas trimetilamīna N-oksīda koncentrācijas novērtēšana eksperimentālajā 2. tipa diabēta modelī. LU 74. zinātniskā konference, Medicīnas bāzes zinātnes un reģeneratīvās medicīnas sekcija; Rīga, Latvija, 19. februāris, 2016; 66.      

Zvejniece L.; Vavers E.; Svalbe B.; Zvejniece B.; Dambrova M. Neuroprotective effects of R-phenibut in experimental models stroke and neuropathic pain. 9th International Symposium on Neuroprotection and Neurorepair; Leipzig, Germany, April 19 - 22, 2016; 23.      

Pajuste Kl.; Petricenko O.; Ruciņš M.; Jackevica L.; Plotniece M.; K. Pajuste; Gulbe A.; Plotniece A.; Gosteva M.; Sobolev A.; Domraceva I. Pyridinium derivatives for development of theranostic nanosystems. Abstract of 2nd International Conference “Current Trends in Cancer Theranostics” (CTCT-2016), Druskininkai, Lithuania, June 19-23, 2016; 72.      

Zvejniece B.; Vāvers E.; Švalbe B.; Dambrova M.; Zvejniece L. R-fenibuta saistīšanās pie lādiņa atkarīgo kalcija jonu kanālu α2–δ subvienības un gabapentīnam līdzīgie pretsāpju efekti. LU 74. zinātniskā konference; Rīga, Latvija, 19. februāris, 2016; 50.      

Vilskersts R.; Dambrova G.; Mezapuke R.; Bandere D.; Dambrova M. Hlorofilīna un resveratrola vazoprotektīvie efekti hipohlorīta izraisītajā endotēlija disfunkcijas modelī in vitro. RSU zinātniskā konference; Rīga, Latvija, 17.-18. marts, 2016.      

Mukane L.; Makrecka-Kuka M.; Vavers E. Impact of Sigma-1 receptor ligands on free calcium level during mitochondrial respiration. RSU International Student Conference in Health and Social Sciences; Riga, Latvia, March 16, 2016.      

Dambrova G.; Mezhapuke R.; Zharkova-Malkova O. ; Bandere D.; Dambrova M. Effects of chlorophyllin and resveratrol on the sodium hypochlorite induced endothelial dysfunction. RSU International Student Conference in Health and Social Sciences; Riga, Latvia, March 16, 2016.      

Vavers E.; Zvejniece L.; Svalbe B.; Domracheva I.; Vilskersts R.; Makrecka - Kuka M.; Veinberg G.; Dambrova M. Allosteric Sigma-1 receptor modulators: a novel approach to treat memory disorders. FEBS/IUBMB “Molecular basis of human diseases: 50 years anniversary of Spetses summer schools”; Spetses island, Greece. May 27-June 1, 2016; 72.      

Plotniece A.; Kozlovska T.; Sobolev A.; Gosteva M.; Bandere D.; Plotniece M.; Ose V.; Vigante B.; Petričenko O.; Timofejeva I.; Vezane A.; Pajuste K. Structure-activity relationships of a series of self-assembling compounds on 1,4-dihydropyridine core as delivery agents. In 30th Conference of The European Colloid and Interface Society, ECIS-2016; Rome, Italy. September 4-9, 2016; 527.      

Upmanis T.; Kreicberga A.; Kazoka H. Investigation of various chromatographic approaches for resolution of foridone and its oxidized form. Book of Abstracts: ISC2016, 31st International Symposium on Chromatography; University College Cork, Ireland. August 28th – September 1st, 2016; 313.      

Stepanovs D.; Yanichev A.; Balodis M.; Beļakovs Sergejs; Mishnev A.F. Pharmaceutical cocrystals of hydrochlorothiazide: Molecular recognition, crystal structures, and selected physicochemical properties, https://elsevier.conference-services.net/viewsecurePDF.asp?conferenceID=3983&abstractID=917624. , 2016.      

Apsīte G.; Vigante B.; Timofejeva I.; Vezane A.; Kozlovska T.; Plotniece A.; Rucins M.; Pajuste K.; Sobolev A. Studies of gene delivery activity of aliphatic cationic head group containing 1,4-dihydropyridine. Book of Abstracts, 13th International Conference on Nanosciences & Nanotechnologies (NN16); Thessaloniki, Greece. July 5-8, 2016; 232.      

*Pajuste K.; Vezane A.; Rucins M.; Gosteva M.; Timofejeva I.; Pajuste Kl.; Petricenko O.; Plotniece M.; Vīgante B.; Kozlovska T.; Sobolev A.; Plotniece A. Structure-activity relationships of a series designed cationic 1,4-dihydropyridines as gene delivery agent. Book of Abstracts, 13th International Conference on Nanosciences & Nanotechnologies (NN16); Thessaloniki, Greece. July 5-8, 2016; 233.